Showing 1 - 8 results of 8 for search 'F.C. De Jong', query time: 0.04s Refine Results
  1. 1
    “It’s My Life and It’s Now or Never”—Transplant Recipients Empowered From a Service-Dominant Logic Perspective

    “It’s My Life and It’s Now or Never”—Transplant Recipients Empowered From a Service-Dominant Logic Perspective by Wim S. Sipma, Margriet F. C. de Jong, Kees C. T. B. Ahaus

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Facing the challenges of PROM implementation in Dutch dialysis care: Patients' and professionals' perspectives.

    Facing the challenges of PROM implementation in Dutch dialysis care: Patients' and professionals' perspectives. by Wim S Sipma, Margriet F C de Jong, Yvette Meuleman, Marc H Hemmelder, Kees C T B Ahaus

    Published 2023-01-01
    Get full text
    Article
  3. 3
    The immaturity of patient engagement in value-based healthcare—A systematic review

    The immaturity of patient engagement in value-based healthcare—A systematic review by Michael van der Voorden, Wim S. Sipma, Margriet F. C. de Jong, Arie Franx, Kees C. T. B. Ahaus

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study

    Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study by Susanne Stads, K. Merijn Kant, Margriet F. C. de Jong, Wouter de Ruijter, Christa M. Cobbaert, Michiel G. H. Betjes, Diederik Gommers, Heleen M. Oudemans-van Straaten

    Published 2019-04-01
    Get full text
    Article
  5. 5
    Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients

    Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients by F.C. De Jong, R. Hoedemaeker, V. Kvikstad, J.T. Mensink, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article
  6. 6
    Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome

    Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome by F.C. De Jong, R.F. Hoedemaeker, V. Kvikstad, J.T.M. Mensink, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article
  7. 7
    Muscle mass, muscle strength and mortality in kidney transplant recipients: results of the TransplantLines Biobank and Cohort Study

    Muscle mass, muscle strength and mortality in kidney transplant recipients: results of the TransplantLines Biobank and Cohort Study by Iris M.Y. vanVliet, Adrian Post, Daan Kremer, Karin Boslooper‐Meulenbelt, Yvonne van derVeen, Margriet F.C. deJong, Robert A. Pol, TransplantLines Investigators, Harriët Jager‐Wittenaar, Gerjan J. Navis, Stephan J.L. Bakker

    Published 2022-12-01
    Get full text
    Article
  8. 8
    PD-L1 expression does not predict BCG-failure in a large cohort of high-risk non-muscle invasive bladder cancer patients

    PD-L1 expression does not predict BCG-failure in a large cohort of high-risk non-muscle invasive bladder cancer patients by F.C. De Jong, R.F. Hoedemaeker, A.M. Van Der Made, V. Kvikstad, T.P.P. Van Den Bosch, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article

Search Tools: